Immunai
About
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
Technology stack
detected 2026-05-24Email
Google Workspace
Stack
jQuery
Bootstrap
WordPress
Analytics
Google Tag Manager
Cookie consent
Cookiebot
Performance
Company Timeline
Capital network
Open in Market Map editorFrequently asked
What does Immunai do?
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
How much funding has Immunai raised?
Immunai has raised a total of $295M in funding. The most recent round on record is Series B.
When was Immunai founded?
Immunai was founded in 2019.
What industry does Immunai operate in?
Immunai operates in Healthcare, Immunology, Data, Analytics, Personalized Treatment, Drug Development.
How many employees does Immunai have?
Immunai has approximately 195 people on record.